tert-Butyl N-methyl-N-{[(3R)-piperidin-3-yl]methyl}carbamate

Catalog No. :
ACUIHC329
CAS No. :
1124199-21-8
Molecular Formula :
C12H24N2O2
Molecular Weight :
228.34

IUPAC Name:tert-butyl (R)-methyl(piperidin-3-ylmethyl)carbamate

tert-Butyl N-methyl-N-{[(3R)-piperidin-3-yl]methyl}carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$273.00Login to see priceInquiryInquiry
100mg97%$399.00Login to see priceInquiryInquiry
250mg97%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl N-methyl-N-{[(3R)-piperidin-3-yl]methyl}carbamate
IUPAC Nametert-butyl (R)-methyl(piperidin-3-ylmethyl)carbamate
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESO=C(OC(C)(C)C)N(C)C[C@H]1CNCCC1
InChI KeyHQZPRFQKDGVCLB-SNVBAGLBSA-N
Synonymtert-butyl (R)-methyl(piperidin-3-ylmethyl)carbamate;(R)-tert-butyl methyl(piperidin-3-ylmethyl)carbamate;Carbamic acid, N-methyl-N-[(3R)-3-piperidinylmethyl]-, 1,1-dimethylethyl ester;TERT-BUTYL N-METHYL-N-([(3R)-PIPERIDIN-3-YL]METHYL)CARBAMATE
CAS No.1124199-21-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUIHC329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQOEL647 route compound structure diagram
    ACQOEL647879275-33-9 In Stock
  2. Then
  3. ACUIHC329 route product structure diagram
    ACUIHC3291124199-21-8
Inquiry

2. ACUIHC329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQOEL647 route compound structure diagram
    ACQOEL647879275-33-9 In Stock
  2. Plus
  3. ACXTWY249 route compound structure diagram
    ACXTWY2491259509-27-7 In Stock
  4. Then
  5. ACUIHC329 route product structure diagram
    ACUIHC3291124199-21-8
Inquiry

Comments (0)